SecSonar.com

Immutep Limited (IMMP)

Immutep Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Immutep Limited (IMMP) is a Biotechnology company based in AU with a market capitalization of $65M. Revenue grew 31.3% year-over-year and free cash flow was negative at -$43.1M. This page tracks IMMP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

AU · 41 employees · IPO Apr 19, 2012

Valuation

Valuation & price

$0.45 · as of May 26, 2026 · -85.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$3.17$1.74$0.31Jul 25Dec 25Jul 26Jul 7, 25$1.68Jul 9, 25$1.69Jul 11, 25$1.65Jul 15, 25$1.63Jul 17, 25$1.69Jul 21, 25$1.71Jul 23, 25$1.68Jul 25, 25$1.72Jul 29, 25$1.76Jul 31, 25$1.74Aug 4, 25$1.74Aug 6, 25$1.75Aug 11, 25$1.70Aug 13, 25$1.73Aug 15, 25$1.73Aug 19, 25$1.77Aug 21, 25$1.64Aug 25, 25$1.70Aug 27, 25$1.66Aug 29, 25$1.61Sep 3, 25$1.63Sep 5, 25$1.65Sep 9, 25$1.60Sep 11, 25$1.66Sep 16, 25$1.69Sep 18, 25$1.69Sep 22, 25$1.71Sep 24, 25$1.69Sep 26, 25$1.72Sep 30, 25$1.75Oct 2, 25$1.88Oct 6, 25$1.95Oct 8, 25$2.02Oct 10, 25$2.01Oct 14, 25$2.09Oct 16, 25$2.10Oct 21, 25$2.06Oct 23, 25$2.01Oct 27, 25$2.04Oct 29, 25$1.97Oct 31, 25$1.89Nov 4, 25$1.76Nov 6, 25$1.65Nov 10, 25$1.74Nov 12, 25$1.79Nov 14, 25$1.85Nov 18, 25$1.75Nov 20, 25$1.69Nov 25, 25$1.81Nov 28, 25$2.03Dec 2, 25$1.84Dec 4, 25$1.78Dec 8, 25$2.27Dec 10, 25$2.50Dec 12, 25$2.58Dec 16, 25$2.49Dec 18, 25$2.62Dec 22, 25$2.76Dec 24, 25$3.08Dec 29, 25$3.01Jan 2, 26$2.95Jan 6, 26$2.94Jan 8, 26$2.98Jan 12, 26$3.07Jan 14, 26$3.10Jan 16, 26$2.94Jan 21, 26$2.83Jan 23, 26$3.17Jan 27, 26$3.08Jan 29, 26$2.97Feb 2, 26$2.86Feb 4, 26$2.70Feb 9, 26$2.73Feb 11, 26$2.79Feb 13, 26$2.64Feb 18, 26$2.80Feb 20, 26$2.79Feb 24, 26$2.80Feb 26, 26$2.74Mar 2, 26$2.67Mar 4, 26$2.73Mar 6, 26$2.76Mar 10, 26$2.76Mar 12, 26$2.76Mar 17, 26$0.41Mar 19, 26$0.41Mar 23, 26$0.39Mar 25, 26$0.37Mar 27, 26$0.35Mar 31, 26$0.35Apr 2, 26$0.36Apr 7, 26$0.36Apr 9, 26$0.32Apr 13, 26$0.31Apr 15, 26$0.54Apr 17, 26$0.58Apr 22, 26$0.59Apr 24, 26$0.57Apr 28, 26$0.49Apr 30, 26$0.46May 4, 26$0.46May 6, 26$0.44May 8, 26$0.45May 12, 26$0.47May 14, 26$0.45May 18, 26$0.49May 20, 26$0.47May 22, 26$0.49May 28, 26$0.44Jun 1, 26$0.40Jun 3, 26$0.41Jun 5, 26$0.38Jun 9, 26$0.37Jun 11, 26$0.36Jun 15, 26$0.37Jun 17, 26$0.37Jun 22, 26$0.38Jun 24, 26$0.39Jun 26, 26$0.39Jul 2, 26$0.42
$0.3152-week range$3.18
Loading valuation history…

Fundamentals

Key fundamentals

$65M

Market cap

31.3%

Revenue growth (YoY)

-1117.5%

Gross margin

-$43.1M

Free cash flow (USD)

-$128.1M

Net debt

Net cash position

21.3%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$175.1KFY 2017$4.2MFY 2018$2.6MFY 2019$139.8KFY 2020$7.5MFY 2021$3.9MFY 2022$170.4KFY 2023$3.5MFY 2024$3.8MFY 2025$5.0M
$175.1K$5M

Free cash flow by year

2016 → 2025

FY 2016$-11.3MFY 2017$-8.5MFY 2018$-7.8MFY 2019$-15.3MFY 2020$-10.9MFY 2021$-17.7MFY 2022$-30.3MFY 2023$-35.9MFY 2024$-35.8MFY 2025$-62.1M
-$11.3M-$62.1M

Gross margin by year

2021 → 2025

FY 2021-346.2%FY 2022-1111.2%FY 202341.2%FY 2024-981.4%FY 2025-1117.5%
-346.2%-1117.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed May 1, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingClinical Data PresentationJun 5, 2026Filing
  • 6-K filingRegulatory UpdateMay 1, 2026Filing
  • Quarterly reportQuarterly Report FiledMay 1, 2026Filing
  • 6-K filingFDA Orphan Drug DesignationApr 16, 2026Filing

Questions

Frequently asked questions

What is Immutep Limited's market cap?

Immutep Limited (IMMP) has a market capitalization of $65M.

What is IMMP's P/E ratio?

A meaningful P/E ratio is not available for IMMP — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying IMMP stock?

SEC Form 4 filings show no open-market insider buys at Immutep Limited in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

VRCA

Verrica Pharmaceuticals Inc.

$64.1M

IMA

ImageneBio Inc

$65.9M

MNOV

MediciNova, Inc.

$66M

RANI

Rani Therapeutics Holdings, Inc.

$63.5M

CBUS

Cibus, Inc.

$66.6M

TCRX

TScan Therapeutics, Inc.

$67.2M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.